IMA MED-TECH joins Biopôle's innovation ecosystem through a new corporate partnership

IMA MED-TECH is pleased to announce a new corporate partnership with Biopôle SA, one of Europe's leading life sciences campuses and innovation hubs.

The agreement further strengthens IMA MED-TECH's presence within the life sciences sector and creates new opportunities to collaborate with innovative companies developing next-generation healthcare technologies. Through this partnership, IMA MED-TECH will contribute its expertise in the industrialisation, automation and high-volume manufacturing of medical devices, diagnostic systems and pharmaceutical delivery solutions.

As the business sector of IMA Automation dedicated to medical assembly technologies, IMA MED-TECH leverages more than sixty years of industrial know-how to support customers throughout the product development journey, from concept validation and process development to scalable manufacturing solutions.

Joining the Biopôle community provides access to a dynamic network of start-ups, scale-ups, researchers and industry stakeholders active across biotechnology, diagnostics, laboratory applications, cell and gene therapy, and advanced healthcare solutions. At the same time, companies within the Biopôle ecosystem can benefit from IMA MED-TECH's expertise in transforming innovative concepts into robust and industrially viable production processes.

"We are proud to partner with Biopôle SA and become part of one of Europe's leading life sciences ecosystems. This collaboration provides IMA MED-TECH with access to a dynamic network that supports our strategic growth in biotechnology, with a focus on diagnostic and laboratory applications, cell and gene therapies, and advanced life science solutions," said Stephane Vuilleumier, CEO of the IMA MEDTECH Business Sector.

"Beyond business opportunities, this partnership fosters collaboration and innovation, creating new synergies for the development of next-generation medical devices and healthcare technologies. We are confident that joining the Biopôle ecosystem will accelerate our innovation journey while further strengthening IMA MED-TECH's long-standing presence in the Neuchâtel region," he added.

Biopôle also highlighted the value of the collaboration for its community.

"Sitting at the intersection of MedTech and automation, IMA MED-TECH brings valuable hands-on expertise in taking projects from early development through to industrialisation and high-volume production. We're excited to make this expertise available to companies across the Biopôle ecosystem, helping them bring innovative solutions from the lab closer to market. At the same time, the partnership opens the door for IMA MED-TECH to connect with new technologies, ideas and opportunities for collaboration."

The partnership confirms IMA MED-TECH's commitment to supporting innovation in medical technologies by enabling a faster and more reliable transition from research and development to industrial-scale manufacturing.